A model organism is a non-human species that is extensively studied to understand particular biological phenomena, with the expectation that discoveries made in the organism model will provide insight into the workings of other organisms. Model organisms are in vivo models and are widely used to research human disease when human experimentation would be unfeasible or unethical. This strategy is made possible by the common descent of all living organisms, and the conservation of metabolic and developmental pathways and genetic material over the course of evolution.
In researching human disease, model organisms allow for better understanding the disease process without the added risk of harming an actual human. The species chosen will usually meet a determined taxonomic equivalency to humans, so as to react to disease or its treatment in a way that resembles human physiology as needed. Although biological activity in a model organism does not ensure an effect in humans, many drugs, treatments and cures for human diseases are developed in part with the guidance of animal models. There are three main types of disease models: homologous, isomorphic and predictive. Homologous animals have the same causes, symptoms and treatment options as would humans who have the same disease. Isomorphic animals share the same symptoms and treatments. Predictive models are similar to a particular human disease in only a couple of aspects, but are useful in isolating and making predictions about mechanisms of a set of disease features.
The use of animals in research dates back to ancient Greece, with Aristotle (384–322 BCE) and Erasistratus (304–258 BCE) among the first to perform experiments on living animals. Discoveries in the 18th and 19th centuries included Antoine Lavoisier's use of a guinea pig in a calorimeter to prove that respiration was a form of combustion, and Louis Pasteur's demonstration of the germ theory of disease in the 1880s using anthrax in sheep.
Research using animal models has been central to most of the achievements of modern medicine. It has contributed most of the basic knowledge in fields such as human physiology and biochemistry, and has played significant roles in fields such as neuroscience and infectious disease. For example, the results have included the near-eradication of polio and the development of organ transplantation, and have benefited both humans and animals. From 1910 to 1927, Thomas Hunt Morgan's work with the fruit fly Drosophila melanogaster identified chromosomes as the vector of inheritance for genes. Drosophila became one of the first, and for some time the most widely used, model organisms, and Eric Kandel wrote that Morgan's discoveries "helped transform biology into an experimental science." D. melanogaster remains one of the most widely used eukaryotic model organisms. During the same time period, studies on mouse genetics in the laboratory of William Ernest Castle in collaboration with Abbie Lathrop led to generation of the DBA ("dilute, brown and non-agouti") inbred mouse strain and the systematic generation of other inbred strains. The mouse has since been used extensively as a model organism and is associated with many important biological discoveries of the 20th and 21st centuries.
In the late 19th century, Emil von Behring isolated the diphtheria toxin and demonstrated its effects in guinea pigs. He went on to develop an antitoxin against diphtheria in animals and then in humans, which resulted in the modern methods of immunization and largely ended diphtheria as a threatening disease. The diphtheria antitoxin is famously commemorated in the Iditarod race, which is modeled after the delivery of antitoxin in the 1925 serum run to Nome. The success of animal studies in producing the diphtheria antitoxin has also been attributed as a cause for the decline of the early 20th-century opposition to animal research in the United States.
Subsequent research in model organisms led to further medical advances, such as Frederick Banting's research in dogs, which determined that the isolates of pancreatic secretion could be used to treat dogs with diabetes. This led to the 1922 discovery of insulin (with John Macleod) and its use in treating diabetes, which had previously meant death. John Cade's research in guinea pigs discovered the anticonvulsant properties of lithium salts, which revolutionized the treatment of bipolar disorder, replacing the previous treatments of lobotomy or electroconvulsive therapy. Modern general anaesthetics, such as halothane and related compounds, were also developed through studies on model organisms, and are necessary for modern, complex surgical operations.
In the 1940s, Jonas Salk used rhesus monkey studies to isolate the most virulent forms of the polio virus, which led to his creation of a polio vaccine. The vaccine, which was made publicly available in 1955, reduced the incidence of polio 15-fold in the United States over the following five years. Albert Sabin improved the vaccine by passing the polio virus through animal hosts, including monkeys; the Sabin vaccine was produced for mass consumption in 1963, and had virtually eradicated polio in the United States by 1965. It has been estimated that developing and producing the vaccines required the use of 100,000 rhesus monkeys, with 65 doses of vaccine produced from each monkey. Sabin wrote in 1992, "Without the use of animals and human beings, it would have been impossible to acquire the important knowledge needed to prevent much suffering and premature death not only among humans, but also among animals."
Other 20th-century medical advances and treatments that relied on research performed in animals include organ transplant techniques, the heart-lung machine, antibiotics, and the whooping cough vaccine. Treatments for animal diseases have also been developed, including for rabies, anthrax, glanders, feline immunodeficiency virus (FIV), tuberculosis, Texas cattle fever, classical swine fever (hog cholera), heartworm, and other parasitic infections. Animal experimentation continues to be required for biomedical research, and is used with the aim of solving medical problems such as Alzheimer's disease, AIDS, multiple sclerosis, spinal cord injury, and other conditions in which there is no useful in vitro model system available.
Selecting a model organism
Models are those organisms with a wealth of biological data that make them attractive to study as examples for other species and/or natural phenomena that are more difficult to study directly. Continual research on these organisms focus on a wide variety of experimental techniques and goals from many different levels of biology—from ecology, behavior, and biomechanics, down to the tiny functional scale of individual tissues, organelles, and proteins. Inquiries about the DNA of organisms are classed as genetic models (with short generation times, such as the fruitfly and nematode worm), experimental models, and genomic parsimony models, investigating pivotal position in the evolutionary tree. Historically, model organisms include a handful of species with extensive genomic research data, such as the NIH model organisms.
Often, model organisms are chosen on the basis that they are amenable to experimental manipulation. This usually will include characteristics such as short life-cycle, techniques for genetic manipulation (inbred strains, stem cell lines, and methods of transformation) and non-specialist living requirements. Sometimes, the genome arrangement facilitates the sequencing of the model organism's genome, for example, by being very compact or having a low proportion of junk DNA (e.g. yeast, arabidopsis, or pufferfish).
When researchers look for an organism to use in their studies, they look for several traits. Among these are size, generation time, accessibility, manipulation, genetics, conservation of mechanisms, and potential economic benefit. As comparative molecular biology has become more common, some researchers have sought model organisms from a wider assortment of lineages on the tree of life.
Phylogeny and genetic relatedness
The primary reason for the use of model organisms in research is the evolutionary principle that all organisms share some degree of relatedness and genetic similarity due to common ancestry. The study of taxonomic human relatives, then, can provide a great deal of information about mechanism and disease within the human body that can be useful in medicine.
Various phylogenetic trees for vertebrates have been constructed using comparative proteomics, genetics, genomics as well as the geochemical and fossil record. These estimations tell us that humans and chimpanzees last shared a common ancestor about 6 million years ago (mya). As our closest relatives, chimpanzees have a lot of potential to tell us about mechanisms of disease (and what genes may be responsible for human intelligence). However, chimpanzees are rarely used in research and are protected from highly invasive procedures. The most common animal model is the rodent. Phylogenetic trees estimate that humans and rodents last shared a common ancestor ~80-100mya. Despite this distant split, humans and rodents have far more similarities than they do differences. This is due to the relative stability of large portions of the genome; making the use of vertebrate animals particularly productive.
Genomic data is used to make close comparisons between species and determine relatedness. Humans share about 99% of our genome with chimpanzees (98.7% with bonobos) and over 90% with the mouse. With so much of the genome conserved across species, it is relatively impressive that the differences between humans and mice can be accounted for in approximately six thousand genes (of ~30,000 total). Scientists have been able to take advantage of these similarities in generating experimental and predictive models of human disease.
Use of model organisms
There are many model organisms. One of the first model systems for molecular biology was the bacterium Escherichia coli, a common constituent of the human digestive system. Several of the bacterial viruses (bacteriophage) that infect E. coli also have been very useful for the study of gene structure and gene regulation (e.g. phages Lambda and T4). However, bacteriophages are not organisms because they lack metabolism and depend on functions of the host cells for propagation.
In eukaryotes, several yeasts, particularly Saccharomyces cerevisiae ("baker's" or "budding" yeast), have been widely used in genetics and cell biology, largely because they are quick and easy to grow. The cell cycle in a simple yeast is very similar to the cell cycle in humans and is regulated by homologous proteins. The fruit fly Drosophila melanogaster is studied, again, because it is easy to grow for an animal, has various visible congenital traits and has a polytene (giant) chromosome in its salivary glands that can be examined under a light microscope. The roundworm Caenorhabditis elegans is studied because it has very defined development patterns involving fixed numbers of cells, and it can be rapidly assayed for abnormalities.
Animal models serving in research may have an existing, inbred or induced disease or injury that is similar to a human condition. These test conditions are often termed as animal models of disease. The use of animal models allows researchers to investigate disease states in ways which would be inaccessible in a human patient, performing procedures on the non-human animal that imply a level of harm that would not be considered ethical to inflict on a human.
The best models of disease are similar in etiology (mechanism of cause) and phenotype (signs and symptoms) to the human equivalent. However complex human diseases can often be better understood in a simplified system in which individual parts of the disease process are isolated and examined. For instance, behavioral analogues of anxiety or pain in laboratory animals can be used to screen and test new drugs for the treatment of these conditions in humans. A 2000 study found that animal models concorded (coincided on true positives and false negatives) with human toxicity in 71% of cases, with 63% for nonrodents alone and 43% for rodents alone.
In 1987, Davidson et al. suggested that selection of an animal model for research be based on nine considerations. These include "1) appropriateness as an analog, 2) transferability of information, 3) genetic uniformity of organisms, where applicable, 4) background knowledge of biological properties, 5) cost and availability, 6) generalizability of the results, 7) ease of and adaptability to experimental manipulation, 8) ecological consequences, and 9) ethical implications."
Animal models can be classified as homologous, isomorphic or predictive. Animal models can also be more broadly classified into four categories: 1) experimental, 2) spontaneous, 3) negative, 4) orphan.
Experimental models are most common. These refer to models of disease that resemble human conditions in phenotype or response to treatment but are induced artificially in the laboratory. Some examples include:
- The use of metrazol (pentylenetetrazol) as an animal model of epilepsy
- Injection of the neurotoxin 6-hydroxydopamine to dopaminergic parts of the basal ganglia as an animal model of Parkinson's disease.
- Immunisation with an auto-antigen to induce an immune response to model autoimmune diseases such as Experimental autoimmune encephalomyelitis
- Occlusion of the middle cerebral artery as an animal model of ischemic stroke
- Injection of blood in the basal ganglia of mice as a model for hemorrhagic stroke
- Infecting animals with pathogens to reproduce human infectious diseases
- Injecting animals with agonists or antagonists of various neurotransmitters to reproduce human mental disorders
- Using ionizing radiation to cause tumors
- Using gene transfer to cause tumors
- Implanting animals with tumors to test and develop treatments using ionizing radiation
- Genetically selected (such as in diabetic mice also known as NOD mice)
- Various animal models for screening of drugs for the treatment of glaucoma
- The use of the ovariectomized rat in osteoporosis research
- Use of Plasmodium yoelii as a model of human malaria
Spontaneous models refer to diseases that are analogous to human conditions that occur naturally in the animal being studied. These models are rare, but informative. Negative models essentially refer to control animals, which are useful for validating an experimental result. Orphan models refer to diseases for which there is no human analog and occur exclusively in the species studied.
The increase in knowledge of the genomes of non-human primates and other mammals that are genetically close to humans is allowing the production of genetically engineered animal tissues, organs and even animal species which express human diseases, providing a more robust model of human diseases in an animal model.
Animal models observed in the sciences of psychology and sociology are often termed animal models of behavior. It is difficult to build an animal model that perfectly reproduces the symptoms of depression in patients. Animals lack self-consciousness, self-reflection and consideration; moreover, hallmarks of the disorder such as depressed mood, low self-esteem or suicidality are hardly accessible in non-humans. However, depression, as other mental disorders, consists of endophenotypes that can be reproduced independently and evaluated in animals. An ideal animal model offers an opportunity to understand molecular, genetic and epigenetic factors that may lead to depression. By using animal models, the underlying molecular alterations and the causal relationship between genetic or environmental alterations and depression can be examined, which would afford a better insight into pathology of depression. In addition, animal models of depression are indispensable for identifying novel therapies for depression.
Important model organisms
Model organisms are drawn from all three domains of life, as well as viruses. The most widely studied prokaryotic model organism is Escherichia coli (E. coli), which has been intensively investigated for over 60 years. It is a common, gram-negative gut bacterium which can be grown and cultured easily and inexpensively in a laboratory setting. It is the most widely used organism in molecular genetics, and is an important species in the fields of biotechnology and microbiology, where it has served as the host organism for the majority of work with recombinant DNA.
Simple model eukaryotes include baker's yeast (Saccharomyces cerevisiae) and fission yeast (Schizosaccharomyces pombe), both of which share many characters with higher cells, including those of humans. For instance, many cell division genes that are critical for the development of cancer have been discovered in yeast. Chlamydomonas reinhardtii, a unicellular green alga with well-studied genetics, is used to study photosynthesis and motility. C. reinhardtii has many known and mapped mutants and expressed sequence tags, and there are advanced methods for genetic transformation and selection of genes. Dictyostelium discoideum is used in molecular biology and genetics, and is studied as an example of cell communication, differentiation, and programmed cell death.
Among invertebrates, the fruit fly Drosophila melanogaster is famous as the subject of genetics experiments by Thomas Hunt Morgan and others. They are easily raised in the lab, with rapid generations, high fecundity, few chromosomes, and easily induced observable mutations. The nematode Caenorhabditis elegans is used for understanding the genetic control of development and physiology. It was first proposed as a model for neuronal development by Sydney Brenner in 1963, and has been extensively used in many different contexts since then. C. elegans was the first multicellular organism whose genome was completely sequenced, and as of 2012, the only organism to have its connectome (neuronal "wiring diagram") completed.
Arabidopsis thaliana is currently the most popular model plant. Its small stature and short generation time facilitates rapid genetic studies, and many phenotypic and biochemical mutants have been mapped. Arabidopsis was the first plant to have its genome sequenced. Among vertebrates, guinea pigs (Cavia porcellus) were used by Robert Koch and other early bacteriologists as a host for bacterial infections, becoming a byword for "laboratory animal," but are less commonly used today. The classic model vertebrate is currently the mouse (Mus musculus). Many inbred strains exist, as well as lines selected for particular traits, often of medical interest, e.g. body size, obesity, muscularity, and voluntary wheel-running behavior.
Among vertebrates, the rat (Rattus norvegicus) is particularly useful as a toxicology model, and as a neurological model and source of primary cell cultures, owing to the larger size of organs and suborganellar structures relative to the mouse, while eggs and embryos from Xenopus tropicalis and Xenopus laevis (African clawed frog) are used in developmental biology, cell biology, toxicology, and neuroscience Likewise, the zebrafish (Danio rerio) has a nearly transparent body during early development, which provides unique visual access to the animal's internal anatomy during this time period. Zebrafish are used to study development, toxicology and toxicopathology, specific gene function and roles of signaling pathways.
Other important model organisms and some of their uses include: T4 phage (viral infection), Tetrahymena thermophila (intracellular processes), maize (transposons), hydras (regeneration and morphogenesis), cats (neurophysiology), chickens (development), dogs (respiratory and cardiovascular systems), Nothobranchius furzeri (aging), and non-human primates such as the rhesus macaque and chimpanzee (hepatitis, HIV, Parkinson's disease, cognition, and vaccines).
Selected model organisms
The organisms below have become model organisms because they facilitate the study of certain characters or because of their genetic accessibility. For example, E. coli was one of the first organisms for which genetic techniques such as transformation or genetic manipulation has been developed.
The genomes of all model species have been sequenced, including their mitochondrial/chloroplast genomes. Model Organism Databases exist to provide researchers with a portal from which to download sequences (DNA, RNA, or protein) or to access functional information on specific genes, for example the sub-cellular localization of the gene product or its physiological role.
|Model Organism||Usage (examples)|
|Prokaryote||Escherichia coli||bacterial genetics, metabolism|
|Eukaryote, unicellular||Dictyostelium discoideum|
|Saccharomyces cerevisiae||cell division, organelles, etc.|
|Schizosaccharomyces pombe||cell cycle, cytokinesis, chromosome biology, telomeres, DNA metabolism, cytoskeleton organization|
|Eukaryote, multicellular||Caenorhabditis elegans||differentiation, development|
|Drosophila melanogaster||developmental biology|
|Vertebrate||Danio rerio||embryonic development|
|Nothobranchius furzeri||aging, disease, evolution|
|Anolis carolinensis||reptile biology, evolution|
|Mus musculus||disease model for humans|
|Xenopus laevis (Note: and X. tropicalis)||embryonic development|
Limitations of model organisms
Many animal models serving as test subjects in biomedical research, such as rats and mice, may be selectively sedentary, obese and glucose intolerant. This may confound their use to model human metabolic processes and diseases as these can be affected by dietary energy intake and exercise. Similarly, there are differences between the immune systems of model organisms and humans that lead to significantly altered responses to stimuli, although the underlying principles of genome function may be the same.
Ethical concerns, as well as the cost, maintenance and relative inefficiency of animal research has encouraged development of alternative methods for the study of disease. Cell culture, or in vitro studies, provide an alternative that preserves the physiology of the living cell, but does not require the sacrifice of an animal for mechanistic studies. Human, inducible pluripotent stem cells can also elucidate new mechanisms for understanding cancer and cell regeneration. Imaging studies (such as MRI or PET scans) enable non-invasive study of human subjects. Recent advances in genetics and genomics can identify disease-associated genes, which can be targeted for therapies.
Debate about the ethical use of animals in research dates at least as far back as 1822 when the British Parliament enacted the first law for animal protection preventing cruelty to cattle. This was followed by the Cruelty to Animals Act of 1835 and 1849, which criminalized ill-treating, over-driving, and torturing animals. In 1876, under pressure from the National Anti-Vivisection Society, the Cruelty to Animals Act was amended to include regulations governing the use of animals in research. This new act stipulated that 1) experiments must be proven absolutely necessary for instruction, or to save or prolong human life; 2) animals must be properly anesthetized; and 3) animals must be killed as soon as the experiment is over. Today, these three principles are central to the laws and guidelines governing the use of animals and research. In the U.S., the Animal Welfare Act of 1970 (see also Laboratory Animal Welfare Act) set standards for animal use and care in research. This law is enforced by APHIS’s Animal Care program.
In academic settings in which NIH funding is used for animal research, institutions are governed by the NIH Office of Laboratory Animal Welfare (OLAW). At each site, OLAW guidelines and standards are upheld by a local review board called the Institutional Animal Care and Use Committee (IACUC). All laboratory experiments involving living animals are reviewed and approved by this committee. In addition to proving the potential for benefit to human health, minimization of pain and distress, and timely and humane euthanasia, experimenters must justify their protocols based on the principles of Replacement, Reduction and Refinement.
Replacement refers to efforts to engage alternatives to animal use. This includes the use of computer models, non-living tissues and cells, and replacement of “higher-order” animals (primates and mammals) with “lower” order animals (e.g. cold-blooded animals, invertebrates, bacteria) wherever possible.
Reduction refers to efforts to minimize number of animals used during the course of an experiment, as well as prevention of unnecessary replication of previous experiments. To satisfy this requirement, mathematical calculations of statistical power are employed to determine the minimum number of animals that can be used to get a statistically significant experimental result.
Refinement refers to efforts to make experimental design as painless and efficient as possible in order to minimize the suffering of each animal subject.
- Ensembl genome database of model organisms
- History of model organisms
- Animals in space
- Animal testing
- Animal testing on invertebrates
- Animal testing on rodents
- Mouse models of colorectal and intestinal cancer
- Mouse models of breast cancer metastasis
- Generic Model Organism Database
- History of animal testing
- RefSeq - the Reference Sequence database
- Genome project
- Fields S, Johnston M (Mar 2005). "Cell biology. Whither model organism research?". Science. 307 (5717): 1885–6. doi:10.1126/science.1108872. PMID 15790833. (registration required (. ))
- Griffiths, E. C. (2010) What is a model? Archived March 12, 2012, at the Wayback Machine.
- Fox, Michael Allen (1986). The Case for Animal Experimention: An Evolutionary and Ethical Perspective. Berkeley and Los Angeles, California: University of California Press. ISBN 0-520-05501-2. OCLC 11754940 – via Google Books.
- Slack, Jonathan M. W. (2013). Essential Developmental Biology. Oxford: Wiley-Blackwell. OCLC 785558800.
- Chakraborty CH, Hsu CH, Wen ZH, Lin CS, Agoramoorthy G (Feb 2009). "Zebrafish: a complete animal model for in vivo drug discovery and development". Current Drug Metabolism. 10 (2): 116–24. doi:10.2174/138920009787522197. PMID 19275547. (subscription required (. ))
- Kari, G.; Rodeck, U.; Dicker, A. P. (July 2007). "Zebrafish: an emerging model system for human disease and drug discovery". Clinical Pharmacology and Therapeutics. 82 (1): 70–80. doi:10.1038/sj.clpt.6100223. ISSN 0009-9236. PMID 17495877.
- "Pinel Chapter 6 - Human Brain Damage & Animal Models". Academic.uprm.edu. Retrieved 2014-01-10.
- Cohen BJ, Loew FM. (1984) Laboratory Animal Medicine: Historical Perspectives in Laboratory Animal Medicine Academic Press, Inc: Orlando, FL, USA; Fox JG, Cohen BJ, Loew FM (eds)
- Royal Society of Medicine (13 May 2015). "Statement of the Royal Society's position on the use of animals in research".
- National Research Council and Institute of Medicine (1988). Use of Laboratory Animals in Biomedical and Behavioral Research. National Academies Press. p. 37. NAP:13195.
- Lieschke GJ, Currie PD (2007). "Animal models of human disease: zebrafish swim into view.". Nat Rev Genet. 8 (5): 353–67. doi:10.1038/nrg2091. PMID 17440532.
- National Research Council and Institute of Medicine (1988). Use of Laboratory Animals in Biomedical and Behavioral Research. National Academies Press. p. 27. NAP:13195.
- Hau and Shapiro 2011:
- Jann Hau; Steven J. Schapiro (2011). Handbook of Laboratory Animal Science, Volume I, Third Edition: Essential Principles and Practices. CRC Press. p. 2. ISBN 978-1-4200-8456-6.
- Jann Hau; Steven J. Schapiro (2011). Handbook of Laboratory Animal Science, Volume II, Third Edition: Animal Models. CRC Press. p. 1. ISBN 978-1-4200-8458-0.
- Institute of Medicine (1991). Science, Medicine, and Animals. National Academies Press. p. 3. ISBN 978-0-309-56994-1.
- "The Nobel Prize in Physiology or Medicine 1933". Nobel Web AB. Retrieved 2015-06-20.
- "Thomas Hunt Morgan and his Legacy". Nobel Web AB. Retrieved 2015-06-20.
- Kohler, Lords of the Fly, chapter 5
- Kandel, Eric. 1999. "Genes, Chromosomes, and the Origins of Modern Biology", Columbia Magazine
- Steensma, David P.; Kyle Robert A.; Shampo Marc A. (November 2010). "Abbie Lathrop, the "Mouse Woman of Granby": Rodent Fancier and Accidental Genetics Pioneer". Mayo Clinic Proceedings. Mayo Foundation for Medical Education and Research. 85 (11): e83. doi:10.4065/mcp.2010.0647. PMC 2966381. PMID 21061734.
- Pillai, Shiv. "History of Immunology at Harvard". Harvard Medical School:About us. Harvard Medical School. Retrieved 19 December 2013.
- Hedrich, Hans (ed.). "The house mouse as a laboratory model: a historical perspective". The Laboratory Mouse. Elsevier Science. ISBN 9780080542539.
- Bering Nobel Biography
- Walter B. Cannon Papers, American Philosophical Society Archived August 14, 2009, at the Wayback Machine.
- Discovery of Insulin Archived September 30, 2009, at the Wayback Machine.
- Thompson bio ref
- John Cade and Lithium
- Raventos J (1956) Brit J Pharmacol 11, 394
- Whalen FX, Bacon DR & Smith HM (2005) Best Pract Res Clin Anaesthesiol 19, 323
- Virus-typing of polio by Salk
- Salk polio virus
- History of polio vaccine
- Carrel A (1912) Surg. Gynec. Obst. 14: p. 246
- Williamson C (1926) J. Urol. 16: p. 231
- Woodruff H & Burg R (1986) in Discoveries in Pharmacology vol 3, ed Parnham & Bruinvels, Elsevier, Amsterdam
- Moore F (1964) Give and Take: the Development of Tissue Transplantation. Saunders, New York
- Gibbon JH (1937) Arch. Surg. 34, 1105
- Hinshaw obituary
- Fleming A (1929) Brit J Exper Path 10, 226
- Medical Research Council (1956) Br. Med. J. 2: p. 454
- A reference handbook of the medical sciences. William Wood and Co., 1904, Edited by Albert H. Buck.
- Pu, R; Coleman, J; Coisman, J; Sato, E; Tanabe, T; Arai, M; Yamamoto, JK (2005). "Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate". Journal of Feline Medicine and Surgery. 7 (1): 65–70. doi:10.1016/j.jfms.2004.08.005. PMID 15686976.
- Dryden, MW; Payne, PA (2005). "Preventing parasites in cats". Veterinary therapeutics : research in applied veterinary medicine. 6 (3): 260–7. PMID 16299672.
- P. Michael Conn (29 May 2013). Animal Models for the Study of Human Disease. Academic Press. p. 37. ISBN 978-0-12-415912-9.
- Lieschke GJ, Currie PD (2007). "Animal models of human disease: zebrafish swim into view.". Nat Rev Genet. 8 (5): 353–67. doi:10.1038/nrg2091. PMID 17440532.
- Pierce K. H. Chow; Robert T. H. Ng; Bryan E. Ogden (2008). Using Animal Models in Biomedical Research: A Primer for the Investigator. World Scientific. pp. 1–2. ISBN 978-981-281-202-5.
- Jann Hau; Steven J. Schapiro (2011). "The contribution of laboratory animals to medical progress". Handbook of Laboratory Animal Science, Volume I, Third Edition: Essential Principles and Practices. CRC Press. ISBN 978-1-4200-8456-6.
- Geula, C; Wu C-K, Saroff D; Lorenzo, A; Yuan, M; Yankner, BA; Yankner, Bruce A. (1998). "Aging renders the brain vulnerable to amyloid β protein neurotoxicity". Nature Medicine. 4 (7): 827–31. doi:10.1038/nm0798-827. PMID 9662375.
- AIDS Reviews 2005;7:67-83 Antiretroviral Drug Studies in Nonhuman Primates: a Valid Animal Model for Innovative Drug Efficacy and Pathogenesis Experiments Archived December 17, 2008, at the Wayback Machine.
- PMPA blocks SIV in monkeys
- PMPA is tenofovir
- Jameson, BA; McDonnell, JM; Marini, JC; Korngold, R (1994). "A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis". Nature. 368 (6473): 744–6. doi:10.1038/368744a0. PMID 8152486.
- Lyuksyutova, AL; Lu C-C, Milanesio N; Milanesio, N; King, LA; Guo, N; Wang, Y; Nathans, J; Tessier-Lavigne, M; et al. (2003). "Anterior-posterior guidance of commissural axons by Wnt-Frizzled signaling". Science. 302 (5652): 1984–8. doi:10.1126/science.1089610. PMID 14671310.
- What are model organisms? Archived October 28, 2006, at the Wayback Machine.
- NIH model organisms Archived August 22, 2007, at the Wayback Machine.
- Hedges, S. B. (2002). "The origin and evolution of model organisms". Nature Reviews Genetics. 3 (11): 838–849. doi:10.1038/nrg929. PMID 12415314.
- Bejerano, G.; Pheasant, M.; Makunin, I.; Stephen, S.; Kent, W. J.; Mattick, J. S.; Haussler, D. (2004). "Ultraconserved Elements in the Human Genome". Science. 304 (5675): 1321–1325. doi:10.1126/science.1098119. PMID 15131266.
- Chinwalla, A. T.; Waterston, L. L.; Lindblad-Toh, K. D.; Birney, G. A.; Rogers, L. A.; Abril, R. S.; Agarwal, T. A.; Agarwala, L. W.; Ainscough, E. R.; Alexandersson, J. D.; An, T. L.; Antonarakis, W. E.; Attwood, J. O.; Baertsch, M. N.; Bailey, K. H.; Barlow, C. S.; Beck, T. C.; Berry, B.; Birren, J.; Bloom, E.; Bork, R. H.; Botcherby, M. C.; Bray, R. K.; Brent, S. P.; Brown, P.; Brown, E.; Bult, B.; Burton, T.; Butler, D. G.; Campbell, J. (2002). "Initial sequencing and comparative analysis of the mouse genome". Nature. 420 (6915): 520–562. doi:10.1038/nature01262. PMID 12466850.
- Kehrer-Sawatzki, H.; Cooper, D. N. (2007). "Understanding the recent evolution of the human genome: Insights from human-chimpanzee genome comparisons". Human Mutation. 28 (2): 99–130. doi:10.1002/humu.20420. PMID 17024666.
- Kehrer-Sawatzki, H.; Cooper, D. N. (2006). "Structural divergence between the human and chimpanzee genomes". Human Genetics. 120 (6): 759–778. doi:10.1007/s00439-006-0270-6. PMID 17066299.
- Prüfer, K.; Munch, K.; Hellmann, I.; Akagi, K.; Miller, J. R.; Walenz, B.; Koren, S.; Sutton, G.; Kodira, C.; Winer, R.; Knight, J. R.; Mullikin, J. C.; Meader, S. J.; Ponting, C. P.; Lunter, G.; Higashino, S.; Hobolth, A.; Dutheil, J.; Karakoç, E.; Alkan, C.; Sajjadian, S.; Catacchio, C. R.; Ventura, M.; Marques-Bonet, T.; Eichler, E. E.; André, C.; Atencia, R.; Mugisha, L.; Junhold, J. R.; Patterson, N. (2012). "The bonobo genome compared with the chimpanzee and human genomes". Nature. 486 (7404): 527–531. doi:10.1038/nature11128. PMC 3498939. PMID 22722832.
- Olson H, Betton G, Robinson D, et al. (August 2000). "Concordance of the toxicity of pharmaceuticals in humans and in animals". Regul. Toxicol. Pharmacol. 32 (1): 56–67. doi:10.1006/rtph.2000.1399. PMID 11029269.
- Davidson, M. K.; Lindsey, J. R.; Davis, J. K. (1987). "Requirements and selection of an animal model". Israel journal of medical sciences. 23 (6): 551–555. PMID 3312096.
- Hughes, H. C.; Lang, C. (1978). "Basic Principles in Selecting Animal Species for Research Projects". Clinical Toxicology. 13 (5): 611–621. doi:10.3109/15563657808988266. PMID 750165.
- White HS (1997). "Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs". Epilepsia. 38 Suppl 1 (s1): S9–17. doi:10.1111/j.1528-1157.1997.tb04523.x. PMID 9092952.
- Halje P, Tamtè M, Richter U, Mohammed M, Cenci MA, Petersson P (2012). "Levodopa-induced dyskinesia is strongly associated with resonant cortical oscillations.". Journal of Neuroscience. 32 (47): 16541–51. doi:10.1523/JNEUROSCI.3047-12.2012. PMID 23175810.
- Bolton C (2007). "The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis". Inflammopharmacology. 15 (5): 183–7. doi:10.1007/s10787-007-1607-z. PMID 17943249.
- Leker RR, Constantini S (2002). "Experimental models in focal cerebral ischemia: are we there yet?". Acta Neurochir. Suppl. 83: 55–9. doi:10.1007/978-3-7091-6743-4_10. PMID 12442622.
- Wang J, Fields J, Doré S (2008). "The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood". Brain Res. 1222: 214–21. doi:10.1016/j.brainres.2008.05.058. PMID 18586227.
- Rynkowski MA, Kim GH, Komotar RJ, et al. (2008). "A mouse model of intracerebral hemorrhage using autologous blood infusion". Nat Protoc. 3 (1): 122–8. doi:10.1038/nprot.2007.513. PMID 18193028.
- Eibl RH, Kleihues P, Jat PS, Wiestler OD (1994). "A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen". Am J Pathol. 144 (3): 556–564. PMC 1887088. PMID 8129041.
- Radner H, El-Shabrawi Y, Eibl RH, Brüstle O, Kenner L, Kleihues P, Wiestler OD (1993). "Tumor induction by ras and myc oncogenes in fetal and neonatal brain: modulating effects of developmental stage and retroviral dose". Acta Neuropathologica. 86 (5): 456–465. doi:10.1007/bf00228580. PMID 8310796.
- Homo-Delarche F, Drexhage HA (2004). "Immune cells, pancreas development, regeneration and type 1 diabetes". Trends Immunol. 25 (5): 222–9. doi:10.1016/j.it.2004.02.012. PMID 15099561.
- Hisaeda H, Maekawa Y, Iwakawa D, et al. (2004). "Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells". Nat. Med. 10 (1): 29–30. doi:10.1038/nm975. PMID 14702631.
- Coppi A, Cabinian M, Mirelman D, Sinnis P (2006). "Antimalarial activity of allicin, a biologically active compound from garlic cloves". Antimicrob. Agents Chemother. 50 (5): 1731–7. doi:10.1128/AAC.50.5.1731-1737.2006. PMC 1472199. PMID 16641443.
- Frischknecht F, Martin B, Thiery I, Bourgouin C, Menard R (2006). "Using green fluorescent malaria parasites to screen for permissive vector mosquitoes". Malar. J. 5 (1): 23. doi:10.1186/1475-2875-5-23. PMC 1450296. PMID 16569221.
- Hasler, G. (2004). "Discovering endophenotypes for major depression". Neuropsychopharmacology. 29 (10): 1765–1781. doi:10.1038/sj.npp.1300506.
- "Bacteria". Microbiologyonline. Retrieved 27 February 2014.
- Chlamydomonas reinhardtii resources at the Joint Genome Institute
- James H. Sang (2001). "Drosophila melanogaster: The Fruit Fly". In Eric C. R. Reeve. Encyclopedia of genetics. USA: Fitzroy Dearborn Publishers, I. p. 157. ISBN 978-1-884964-34-3. Retrieved 2009-07-01.
- Riddle, Donald L. (1997). C. elegans II (Full text). Plainview, N.Y: Cold Spring Harbor Laboratory Press. ISBN 0-87969-532-3.
- Brenner, S (1974). "The Genetics of Caenorhabditis elegans". Genetics. 77 (1): 71–94. PMC 1213120. PMID 4366476.
- White, J; et al. (1986). "The structure of the nervous system of the nematode Caenorhabditis elegans". Philos. Trans. R. Soc. Lond., B, Biol. Sci. 314 (1165): 1–340. doi:10.1098/rstb.1986.0056. PMID 22462104.
- Jabr, Ferris (2012-10-02). "The Connectome Debate: Is Mapping the Mind of a Worm Worth It?". Scientific American. Retrieved 2014-01-18.
- About Arabidopsis on The Arabidopsis Information Resource page (TAIR)
- Kolb, E. M., E. L. Rezende, L. Holness, A. Radtke, S. K. Lee, A. Obenaus, and T. Garland, Jr. 2013. Mice selectively bred for high voluntary wheel running have larger midbrains: support for the mosaic model of brain evolution. Journal of Experimental Biology 216:515-523.
- Wallingford, J.; Liu, K.; Zheng, Y. (2010). "MISSING". Current Biology. 20: R263–4. doi:10.1016/j.cub.2010.01.012.
- Harland, R.M.; Grainger, R.M. (2011). "MISSING". Trends in Genetics. 27: 507–15. doi:10.1016/j.tig.2011.08.003. PMC 3601910. PMID 21963197.
- Spitsbergen JM, Kent ML (2003). "The state of the art of the zebrafish model for toxicology and toxicologic pathology research—advantages and current limitations". Toxicol Pathol. 31 (Suppl): 62–87. doi:10.1080/01926230390174959. PMC 1909756. PMID 12597434.
- Chapman, J. A.; Kirkness, E. F.; Simakov, O.; Hampson, S. E.; Mitros, T.; Weinmaier, T.; Rattei, T.; Balasubramanian, P. G.; Borman, J.; Busam, D.; Disbennett, K.; Pfannkoch, C.; Sumin, N.; Sutton, G. G.; Viswanathan, L. D.; Walenz, B.; Goodstein, D. M.; Hellsten, U.; Kawashima, T.; Prochnik, S. E.; Putnam, N. H.; Shu, S.; Blumberg, B.; Dana, C. E.; Gee, L.; Kibler, D. F.; Law, L.; Lindgens, D.; Martinez, D. E.; et al. (2010). "The dynamic genome of Hydra". Nature. 464 (7288): 592–596. Bibcode:2010Natur.464..592C. doi:10.1038/nature08830. PMID 20228792.
- Harel, I.; Benayoun, B. R. N. A.; Machado, B.; Singh, P. P.; Hu, C. K.; Pech, M. F.; Valenzano, D. R.; Zhang, E.; Sharp, S. C.; Artandi, S. E.; Brunet, A. (2015). "A Platform for Rapid Exploration of Aging and Diseases in a Naturally Short-Lived Vertebrate". Cell. 160 (5): 1013–26. doi:10.1016/j.cell.2015.01.038. PMID 25684364.
- "JGI-Led Team Sequences Frog Genome". GenomeWeb.com. Genome Web. 29 April 2010. Archived from the original on August 7, 2011. Retrieved 30 April 2010.
- Martin B, Ji S, Maudsley S, Mattson MP (2010). ""Control" laboratory rodents are metabolically morbid: Why it matters". Proceedings of the National Academy of Sciences. 107 (14): 6127–6133. doi:10.1073/pnas.0912955107. PMC 2852022. PMID 20194732.
- Mestas, Javier; Hughes, Christopher C. W. (2004-03-01). "Of Mice and Not Men: Differences between Mouse and Human Immunology". The Journal of Immunology. 172 (5): 2731–2738. doi:10.4049/jimmunol.172.5.2731. ISSN 0022-1767. PMID 14978070.
- Schroder, Kate; Irvine, Katharine M.; Taylor, Martin S.; Bokil, Nilesh J.; Cao, Kim-Anh Le; Masterman, Kelly-Anne; Labzin, Larisa I.; Semple, Colin A.; Kapetanovic, Ronan (2012-04-17). "Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages". Proceedings of the National Academy of Sciences. 109 (16): E944–E953. doi:10.1073/pnas.1110156109. ISSN 0027-8424. PMC 3341041. PMID 22451944.
- Seok, Junhee; Warren, H. Shaw; Cuenca, Alex G.; Mindrinos, Michael N.; Baker, Henry V.; Xu, Weihong; Richards, Daniel R.; McDonald-Smith, Grace P.; Gao, Hong (2013-02-26). "Genomic responses in mouse models poorly mimic human inflammatory diseases". Proceedings of the National Academy of Sciences. 110 (9): 3507–3512. doi:10.1073/pnas.1222878110. ISSN 0027-8424. PMC 3587220. PMID 23401516.
- Jubb, Alasdair W; Young, Robert S; Hume, David A; Bickmore, Wendy A (2016-01-15). "Enhancer turnover is associated with a divergent transcriptional response to glucocorticoid in mouse and human macrophages". Journal of immunology (Baltimore, Md. : 1950). 196 (2): 813–822. doi:10.4049/jimmunol.1502009. ISSN 0022-1767. PMC 4707550. PMID 26663721.
- "FDA: Why are animals used for testing medical products?".
- "Society Of Toxicology: Advancing valid alternatives".
- British animal protection legislation.
- AWA policies.
- NIH need-to-know
- list of common model organisms approved for use by the NIH) Archived August 22, 2007, at the Wayback Machine.
- Marx, Vivien (29 May 2014). "Models: stretching the skills of cell lines and mice". Technology Feature. Nature Methods (Paper "Nature Reprint Collection, Technology Features" (Nov 2014)). 11: 617–20. doi:10.1038/nmeth.2966. PMID 24874573. (registration required (. ))
- Wellcome Trust description of model organisms
- WWW Virtual Library guide to several model organism resource lists
- The Generic Model Organism Database project
- The Model Organism Database ftp site and info
- The US National Institutes of Health page
- Model Organisms in Developmental Biology
- Ludwig-Maximillians-Universität Department Biologie II
- [ Zebrafish GenomeWiki Community Annotation Project]
- Workhorse Zoo by Adam Zaretsky
- Disease Animal Models – BSRC Alexander Fleming
- Knock Out Rat Consortium – KORC
- Emice – National Cancer Institute